| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BLUEPRINT MEDICINES CORP COM | 2,895,251 | 58,629,000 | 12.49% | ||
| 2 | CYTOKINETICS INC | 4,989,218 | 47,348,000 | 10.09% | ||
| 3 | CHEMOCENTRYX INC | 8,182,052 | 36,737,000 | 7.83% | ||
| 4 | Exelexis | 22,822,778 | 33,935,000 | 7.23% | PRN | |
| 5 | CONCERT PHARMACEUTICALS INC COM | 2,755,318 | 30,942,000 | 6.59% | ||
| 6 | ARRAY BIOPHARMA INC COM | 8,260,897 | 29,409,000 | 6.27% | ||
| 7 | FORWARD PHARMA A/S | 1,424,611 | 25,885,000 | 5.51% | ||
| 8 | IONIS PHARMACEUTICALS INC | 850,000 | 19,797,000 | 4.22% | ||
| 9 | GLYCOMIMETICS INC | 2,447,415 | 17,793,000 | 3.79% | ||
| 10 | CASCADIAN THERAPEUTICS INC | 18,799,368 | 17,730,000 | 3.78% | ||
| 11 | ONCOMED PHARMACEUTICALS INC | 1,339,336 | 16,487,000 | 3.51% | ||
| 12 | TOBIRA THERAPEUTICS INC | 1,253,401 | 15,743,000 | 3.35% | ||
| 13 | CTI BIOPHARMA CORP | 44,796,940 | 15,231,000 | 3.24% | ||
| 14 | ArQule Inc | 7,450,128 | 14,155,000 | 3.02% | ||
| 15 | XENON PHARMACEUTICALS INC | 1,775,572 | 10,511,000 | 2.24% | ||
| 16 | Nivalis Therapeutics Inc | 1,926,443 | 8,862,000 | 1.89% | ||
| 17 | VITAE PHARMACEUTICALS INC | 761,079 | 8,212,000 | 1.75% | ||
| 18 | PARATEK PHARMACEUTICALS INC | 575,000 | 7,998,000 | 1.70% | ||
| 19 | INFINITY PHARMACEUTICALS INC COM | 5,184,600 | 6,896,000 | 1.47% | ||
| 20 | GTX INC | 11,512,000 | 6,332,000 | 1.35% | ||
| 21 | CYTOMX THERAPEUTICS INC COM | 606,138 | 6,192,000 | 1.32% | ||
| 22 | ADURO BIOTECH | 513,603 | 5,809,000 | 1.24% | ||
| 23 | MACROGENICS INC | 200,000 | 5,398,000 | 1.15% | ||
| 24 | Esperion Therapeutics Inc | 499,142 | 4,932,000 | 1.05% | ||
| 25 | PAIN THERAPEUTICS INC | 2,149,913 | 4,708,000 | 1.00% | ||
| 26 | QLT INC | 2,255,476 | 3,203,000 | 0.68% | ||
| 27 | Sunesis Pharmaceuticals I | 4,813,294 | 2,636,000 | 0.56% | ||
| 28 | Orexigen Therapeutics, Inc. | 5,252,100 | 2,258,000 | 0.48% | ||
| 29 | MAST THERAPEUTICS | 3,696,961 | 1,738,000 | 0.37% | ||
| 30 | Catalyst Biosciences | 970,948 | 1,476,000 | 0.31% | ||
| 31 | GLOBEIMMUNE INC | 657,653 | 1,276,000 | 0.27% | ||
| 32 | CALITHERA BIOSCIENCES INC | 121,400 | 450,000 | 0.10% | ||
| 33 | Pieris Pharmaceuticals | 241,352 | 389,000 | 0.08% | ||
| 34 | AVIRAGEN THERAPEUTICS INC | 208,353 | 292,000 | 0.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000921895-16-005495, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
